Results 121 to 130 of about 4,368 (201)

Finerenone in People with CKD, Type 2 Diabetes, and History of Nephrectomy.

KEY POINTS: Finerenone reduced albuminuria versus placebo in patients with a history of nephrectomy, similar to those without a history of nephrectomy.
Weir, Matthew R, Ahlers, Christiane, Horvat-Broecker, Andrea, Fatoba, Samuel T, Mendoza, Jair Munoz, Fornoni, Alessia, Rohwedder, Katja, Anker, Stefan D, Kopyt, Nelson, DO, FASN, FACP, Rossing, Peter, Filippatos, Gerasimos, Brinker, Meike   +11 more
core  

Diagnostic challenges in primary aldosteronism evaluation and finerenone use. [PDF]

J Med Case Rep
Xu Y, Song K, Wu S, Li J, Pan S.
europepmc   +1 more source

A Process for the purification of Finerenone

The present invention relates to process for the purification of (4S)­4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide which is referred to as Finerenone and is represented by the following structural formula ...
, MSN Laboratories Private Limited, R&D Center; Srinivasan Thirumalai Rajan, Sagyam Rajeshwar Reddy, Velishala Praveen
core  

Antiproteinuric Response to Finerenone in Diabetic Kidney Disease: Responder and Non-Responder Subgroup Analysis of the FINDKDLATAM Study. [PDF]

Clin Pract
Rico Fontalvo J, Raad Sarabia M, De La Flor JC, Sánchez Polo V, Benavides Garcia J, Ramos Clason E, Domínguez D, Mera Rebutti G, Madrid Mancia C, Tabora López R, Rocha Meza M, Tabora López D, Muñoz Zambrano JJ, Lorca Herrera E, Dina-Batlle E, Cieza Terrones M, Pedroza Pallares A, Rodríguez Yánez T, Osorio W, Arellano Cabeza A, Felipe Gutiérrez J, Chandu Nanwani A, Rodríguez Tudero C, Daza Arnedo R.   +23 more
europepmc   +1 more source

Non-albumin proteinuria as a candidate biomarker of treatment response to finerenone in diabetic kidney disease: a real-world cohort study. [PDF]

Front Endocrinol (Lausanne)
Choi MS, Kim HW, Yu M, Lee M, Lee YH, Kang ES, Cha BS, Lee BW.   +7 more
europepmc   +1 more source

Twenty-Four-Week UACR Response Trajectories and Clinical Correlates of Residual Albuminuria in Diabetic Kidney Disease During Finerenone Therapy: A Real-World Longitudinal Study. [PDF]

Diabetes Metab Syndr Obes
Zhang Y, Zhu Q, Wang C, Cai X, Lin S, Ding B, Zhu X, Lin Y.   +7 more
europepmc   +1 more source

Chinese Expert Consensus on the Clinical Application of Finerenone in Geriatric Comorbidities: Geriatrics Branch of Chinese Medical Association, Cardiovascular Group of Geriatrics Branch of Chinese Medical Association. [PDF]

Aging Med (Milton)
Wang X, Zhang C.
europepmc   +1 more source

PRO/CON debate: nonsteroidal versus steroidal mineralocorticoid receptor antagonists in chronic kidney disease: progress, pragmatism, and remaining uncertainties. [PDF]

Clin Kidney J
Agarwal R, Vogt L, Floege J, Zoccali C.
europepmc   +1 more source

Efficacy and safety of finerenone in adults with IgA nephropathy: a 12-month real-world study. [PDF]

Ren Fail
Pei J, Sun X, Xu X, Bai P, Huang R, Zhang J, Chen X, Yao L, Shao L, Li Y.   +9 more
europepmc   +1 more source

Finerenone exposure and ischaemic stroke in patients with type 2 diabetes and chronic kidney disease: A propensity score-matched cohort study. [PDF]

Clin Med (Lond)
Chuang WL, Chou RH, Wang YH, Tsai IJ, Lin CL, Cho DY, Chang KH.   +6 more
europepmc   +1 more source